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a b s t r a c t
Reactive oxygen species have been implicated in feeding control through involvement in brain lipid
sensing, and regulating NPY/AgRP and pro-opiomelanocortin (POMC) neurons, although the underlying
mechanisms are unclear. Nitric oxide is a signaling molecule in neurons and it stimulates feeding in many
species. Whether reactive oxygen species affect feeding through interaction with nitric oxide is unclear.
We previously reported that Immp2l mutation in mice causes excessive mitochondrial superoxide
generation, which causes infertility and early signs of aging. In our present study, reduced food intake
in mutant mice resulted in signiﬁcantly reduced body weight and fat composition while energy
expenditure remained unchanged. Lysate from mutant brain showed a signiﬁcant decrease in cGMP
levels, suggesting insufﬁcient nitric oxide signaling. Thus, our data suggests that reactive oxygen species
may regulate food intake through modulating the bioavailability of nitric oxide.
& 2013 The Authors. Published by Elsevier B.V.
Introduction
Reactive oxygen species (ROS) are implicated in feeding reg-
ulation through various mechanisms. For example, ROS are
involved in brain lipid sensing, which regulates food intake [1].
Additionally, regulation of free radical generation in the mitochon-
dria by UCP2 mediates ghrelin's action on NPY/AgRP neurons [2];
suppression of ROS promotes feeding by diminishing the activa-
tion of pro-opiomelanocortin (POMC) neurons and enhancing the
activity of NPY/AgRP neurons, whereas expression of ROS activates
POMC neurons and reduces feeding [3]. Whether alternate
mechanisms are involved in ROS regulation of feeding requires
further investigation.
Nitric oxide (NO), a signaling messenger, is involved in feeding
control in multiple species, including chicken [4,5], mice [6–9] and
rats [10,11]; moreover, NO is a central component in neuropeptide
regulation of appetite [12]. Blockade of NO synthesis reduces
adiposity in high fat-induced obese mice [13] and obese Zucker
rats [14]. Three nitric oxide synthases (NOS), the constitutive
neuronal NOS (nNOS), endothelial NOS (eNOS), and the inducible
NOS (iNOS), are responsible for the synthesis of NO. Leptin, a
hormone produced by adipocytes, inhibits brain NO synthesis and
decreases food intake [15,16]. Guanylate cyclase, the principal NO
receptor, synthesizes cyclic guanosine monophosphate (cGMP)
upon activation by NO.
The hypothalamus is a critical part of the brain that contains nuclei,
such as the arcuate nucleus (ARC), the ventromedial nucleus (VMN)
and the dorsomedial nucleus (DMN), which contain multiple neurons
that receive signals from insulin and leptin to regulate food intake
[17–19]. In the ARC, neuropeptide Y (NPY) and Agouti-related peptide
(AgRP), which are co-expressed by NPY/AgRP neurons, stimulate food
intake [20–24]. Gene products from pro-opiomelanocortin (POMC)
and cocaine- and amphetamine-regulated transcript (CART), which
are co-expressed by POMC neurons, suppress food intake [25,26];
therefore, ROS may be acting through NPY/AgRP and POMC neurons
[2,3]. Pharmacological activation of AMP-activated protein kinase
(AMPK) in the hypothalamus will cause increased food intake [27],
NO production, and neuronal activity [28]. AMPK is activated via
phosphorylation of threonine 172 of AMPKα subunit [29].
Superoxide and NO have opposing effects on blood vessel
contraction [30]. The reaction of superoxide with NO yields per-
oxynitrite at a speed several times faster than its own dismutation
by superoxide dismutases [31–33]. Recently, we generated the
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Immp2l mutant mouse model through random transgenic inser-
tional mutagenesis [34,35]. IMMP2L is a mitochondrial inner
membrane peptidase, which cleaves the space-sorting signal
peptide sequences from cytochrome c1 (CYC1) and mitochondrial
glycerol phosphate dehydrogenase (GPD2). Accordingly, the signal
peptide sequences of CYC1 and GPD2 are not cleaved in Immp2l
mutant mice. The mitochondria from mutant mice generate
excessive superoxide ions, but they show no obvious deﬁciencies
in ATP generation and membrane potential maintenance [35].
Mutant mice exhibit erectile dysfunction [35], defective oogenesis
[35] and bladder dysfunction [36], which may result from inacti-
vation of NO by superoxide. The mutant mice also develop age-
dependent spermatogenic impairment [35,37], accelerated aging
[38], and increased ischemic brain damage [39] due to increased
oxidative stress.
While studying the effects of mitochondrial superoxide over-
generation on aging, we noted that mutant mice have signiﬁ-
cantly reduced body weight and fat composition compared to
control mice after the age of 5 months. Data from our present
study suggest that decreased food intake may account for
reduced body weight and adiposity in mutant mice; furthermore,
our data suggest that the mechanism of food intake decrease




The generation of Immp2lTg(Tyr)979Ove/Immp2lTg(Tyr)979Ove mutant
mice has been described previously [35], and the mice have been
maintained on an FVB/N background. Lepob/ob mice have been
described previously [40], and animals were purchased from The
Jackson Laboratories. The mice were backcrossed to FVB/N back-
ground for ﬁve generations before crossing with Immp2l hetero-
zygous mice. Immp2l and Leptin double mutant mice were
generated by mating double heterozygous males and females.
Mice were housed in the pathogen-free animal facility of Wake
Forest University Health Sciences. Experiments were conducted in
accordance with the National Research Council publication Guide
for Care and Use of Laboratory Animals, and approved by the
Institutional Animal Care and Use Committee of Wake Forest
University Health Sciences. Mice were kept in microisolator cages
with 12-h light/dark cycles and were fed ad libitum on a chow diet
(Prolab, RMH3000). Genotypes of the mice were determined by
coat color [35].
Food consumption
Food consumption was determined for mice that were indivi-
dually caged in cages with lifted wire bottoms, as described
previously [41]. Food spilled on the bottom of the cages was
recovered and subtracted from food intake. Unless otherwise
stated, the number of animals per group was equal to or greater
than ﬁve. Food intake was assayed prior to noticeable differences
in body weight between control and mutant mice. Food intake was
normalized to body mass and analyzed by Student's t-test, and
p values o0.05 were regarded as statistically signiﬁcant.
To compare fasting induced food intake, mice were individually
housed in cages with lifted wire bottoms, fasted for 15 h (from
6:00 pm to 9:00 am) or 16 h (from 10:00 pm to 2:00 pm), and
then provided with food. Food intake during the ﬁrst 4 h was
recorded and compared by Student's t-test.
Blood biochemical assays
Sera were collected from mice following 6 h fasting. Free fatty
acids were assayed with kits from Cayman Chemical (Ann Arbor,
MI). Serum leptin, insulin, cholesterol and triglyceride were
assayed as described previously [41].
Determination of cGMP and nitrate/nitrite concentrations
To avoid cGMP degradation, mice were euthanized by cervical
dislocation and brain removed within 2–3 min after death. The
hypothalami were dissected and snap frozen in liquid nitrogen,
and stored at 80 1C prior to measuring hypothalamic cGMP
concentrations. The hypothalamic tissues were lysed in 5% tri-
chloroacetic acid (10 ml solution per 1 g tissue) and extracted with
water-saturated ether. A Monoclonal Anti-cGMP EIA Kit without
Acetylation from Neweast Biosciences Inc. (Cat# 80103) was used
to compare cGMP according to manufacturer's protocol. Total
nitrate and nitrite contents in the trichloroacetic acid extracts
were assayed with a kit from Cayman Chemical.
Magnetic resonance imaging (MRI) analysis of fat composition
Fat composition was determined by MRI using the Bruker
Biospin 7 T microMRI scanner housed in the Center for Biomole-
cular Imaging, Wake Forest University Health Sciences as
described previously [41].
Metabolic studies
Indirect calorimetry and locomotor activity were measured
using the Oxymax CLAMS system (Columbus Instruments).
Animals were tested at 4 months of age and prior to noticeable
differences in body weight and fat composition. Oxygen consump-
tion rate (VO2) and CO2 production rate (VCO2) in individual mice
were measured using metabolic chambers, and the respiratory
exchange ratio (RER) was calculated to reﬂect energy expenditure.
A photobeam-based activity monitoring systemwas used to detect
and record ambulatory movements. The temperature of the
cabinet was set at 26 1C. Energy expenditure (kJ/h) was calculated
using the formula: VO2 [3.815þ(1.232RER)]4.1868) [42] and
was normalized to body weight since control and mutant mice
showed similar body weight at the time of assay. All parameters
were measured continuously and simultaneously for 72 h after
36 h of adaptation in singly housed mice. Three-day averages for
each mouse were used for analysis.
Quantitative RT-PCR analysis of gene expression
Total RNA was extracted from hypothalamic tissues with
Turbo DNase (Ambion) to eliminate DNA contamination, and
reverse transcribed as described previously [43]. Primers for
Npy, Agrp and Pomc have been described in our recent publica-
tion [41]. Other primers used include: pmchF (agcggtttcatgaac-
gatg) and pmchR (tcagacttgccaacatggtc) for Pro-melanin-
concentrating hormone, OrexinF (gggtatttggaccactgcac) and
OrexinR (ttcgtagagacggcaggaac) for Orexin gene, sGCF
(ctgctggtgatccgcaattat) and sGCR (gatggtatcatagccagactcct) for
Soluble guanylyl cyclase, eNOSF (ccttccgctaccagccaga) and eNOSR
(cagagatcttcactgcattggcta) for eNos, nNOSF (tcctaaatccagcc-
gatcga) and nNOSR (tcatggttgccagggaagac) for nNos, and iNOSF
(agagagatccgatttagagtcttggt) and iNOSR (tgacccgtgaagccatgac)
for iNos. Equal amounts of RNA from ﬁve mice per group were
mixed for RT-PCR analysis. Mean7SEM was obtained from
three to four independent PCR analyses, with each PCR analysis
including triplicate wells.
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SDS–PAGE and Western blotting analyses
Hypothalamic tissue were homogenized in RIPA buffer contain-
ing protease inhibitors (0.5 mM PMSF and 1 Complete Protease
Inhibitor Cocktail, Roche) and phosphatase inhibitors (50 mM NaF,
1.5 mM Na3VO3). Anti-β-actin antibody was from Sigma; antibody
to phosphorylate AMPK was from Millipore. Horseradish perox-
idase (HRP)-conjugated secondary antibodies were purchased
from Pierce. Chemiluminescent reagents from Pierce were used
to visualize the protein signals under the LAS-3000 system from
Fujiﬁlm. ImageJ software was used to quantify the expression of
individual protein bands and normalized to β-actin. Student's t-
test was used to compare protein expression between control and
mutant mice.
Adipose-derived stromal cell (ADSC) isolation and culture
Gonadal white adipose tissues were weighed, minced, and
digested with 0.1% collagenase I for 1 h at 37 1C. The digested
tissues were centrifuged at 3000 rpm for 10 min to separate
adipose-derived stromal cells (ADSCs) from mature fat cells. The
isolated ADSCs were cultured in MEM-α medium (Invitrogen)
supplemented with 10% FBS, 5 ng/ml FGF2, and antibiotics. Freshly
isolated ADSCs (1/50 cells from the mouse with the smallest tissue,
the remaining mice were normalized by adipose tissue mass) were
plated in 6-well dishes. After 10 days of culture, the cells were
ﬁxed with methanol for 5 min at room temperature and stained
for 30 min with Giemsa staining. For proliferation assay, the cells
were plated at a density of 5104 cells/well in 6-well plates. After
reaching conﬂuence, the cells were trypsinized and counted and
5104 cells were re-plated for expansion.
Results
Immp2l mutant mice have reduced body weight and fat deposition
Both male and female adult Immp2l mutant mice gained little
body weight from 3 months to 20 months, while control mice
gained signiﬁcant weight during this time (Fig. 1A, females, and
Fig. 1B, males). Since mutant mice did not show age-associated
symptoms until 16 months [38], failure to gain weight cannot
be explained by accelerated aging. Comparing fat composition
between control and mutant female mice at 15 months of age
revealed that mutant mice had signiﬁcantly reduced fat mass
and fat composition than control mice, and reduced fat mass
accounted for a major part of the body weight difference (Fig. 1C).
Blood lipids, insulin and leptin concentrations were compared
between control and mutant mice (Table 1). These parameters
were similar between control and mutant mice at 3 months of age
when body weights were similar. Control mice, however, had
signiﬁcantly higher leptin, insulin and triglyceride levels than
mutant mice after 12 months of age, and they showed higher
adiposity than mutant mice. Free fatty acids and cholesterol levels
were similar between control and mutant mice regardless of age.
Mutant mice have reduced food intake
Reduced adiposity in mutants could be caused by reduced food
intake, increased energy expenditure, or both. Previously, we
observed no difference in food intake/body weight ratios between
6 and 7-month-old control and mutant mice [38]. At this age,
control and mutant mice showed signiﬁcant difference in body
weight and fat composition; thus, food intakes were compared at
3 months of age and their body weight showed no difference. The
Fig. 1. Reduced body weight and adiposity of Immp2l mutant mice. (A) Body weight of female mice at different ages. Ad-lib indicates fed ad libitum. (B) Body weight of male
mice. (C) Body weight and fat composition of 16-month-old female mice. Total fat composition was determined by MRI. Means7SEM. for nZ5 animals per group are
represented. *, ** and ***, po0.05, po0.01 and po0.0001 respectively by Bonferroni post-tests ((A), (C) and (D)) and Tukey post-tests (B) following ANOVA.
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absolute daily food intake and food/body weight ratio were both
reduced by 30% in mutant mice (Table 2). Although mutant mice
had an earlier recorded reduced food intake, their body weight
was not different from control mice until after 5 months. This may
be due to low adiposity in young mice, including control animals,
and differences are detectable as the animal's age and adipose
tissue constitutes a larger percentage of total body weight.
As observed in female mice, differences in body weight of
older male mice were a result of variable accumulation of fat
(data not shown). Food intake was compared in 13-month-old
male mice. Consistent with data in Fig. 1B, control males had
signiﬁcantly higher body weight than mutant males at the same
age (Table 2). Food intake of control male mice was larger than
that of mutant males, but the difference did not achieve statis-
tical signiﬁcance. An increased sample size would be necessary to
observe the difference.
Food intake was further characterized in female mice prior
to observable differences in body weight. The accumulative food
intake during 24 h was decreased in mutant mice (Fig. 2A); moreover,
this decrease was caused by signiﬁcantly reduced food intake between
14:00 pm and 22:00 pm, which is the time that food consumption is
highest in control mice (Fig. 2B). Between 22:00 pm and 14:00 pm,
mutant mice had similar food intake compared to control mice.
Reduction of food intake in mutant mice is not explained by the
number of meals or time spent feeding, especially during 18:00 pm to
22:00 pm (Fig. 2C and D).
Fasting abolished the food intake difference between control
and mutant mice, as fasted mutant mice had similar food intake
compared to fasted control mice during 9:00 am and 13:00 pm
(Fig. 2E), when non-fasted control and mutant mice showed no
food intake difference, and during 14:00 pm to 18:00 pm (Fig. 2F),
when non-fasted mutant mice had reduced food intake. These
data suggest that the effects of fasting on food intake override the
effects of Immp2l gene mutation. Neural peptide Y, agouti antigen-
related peptide, pro-opiomelanocortin-derived peptides, melanin-
concentrating hormone, and orexin all control appetite via neural
interactions in the hypothalamus. We examined the expression of
Npy, Agrp, Pomc, Mch, and Orexin, genes coding for these appetite
controlling peptides, and found no difference between control and
mutant mice (Fig. 2G).
Pair-feeding equalizes body weight and adiposity of control and
mutant mice
To examine whether food intake accounts for the reduced
adiposity of mutant mice, control mice were fed the equivalent
amount of food consumed by mutant mice from the age of 6 weeks.
Pair-fed control mice and ad libitum-fed mutant mice had similar
body weight up to the age of 20 months (Fig. 1A, dashed line). In
addition to similar body weight, they also had similar body
compositions (Fig. 3A). These data demonstrate that reduced body
weight of mutant mice is the result of reduced food intake.
We previously reported that adipose-derived stromal cells
(ADSCs) isolated from older mutant mice showed impaired pro-
liferation [38]. The observation of reduced food intake and fat
accumulation in mutant mice prompted us to examine whether
impaired ADSC proliferation of mutant mice is a consequence of
reduced food intake and adiposity. Since pair-fed control mice
have similar body weight and adiposity compared to mutant mice,
we isolated ADSC from age-matched pair-fed control mice and ad
libitum-fed mutant mice at ages 22–25 months and cultured these
cells at low density to assess colony formation. Colonies obtained
from control mice were signiﬁcantly larger in number and size
compared to colonies observed from the mutant mice (Fig. 3B).
ADSC from control and mutant mice were both cultured for one
week, and cell numbers were counted at time of cell passage. More
cells were obtained from control mice than from mutant mice
(Fig. 3C). These observations were similar to previous observations
made from ad libitum-fed control and mutant mice [38].
Mutant mice have normal energy expenditure
Energy expenditure was further examined by indirect calori-
metry in 12 to 16-week-old control and mutant mice prior to
observable differences in body weight (Fig. 4A). The respiratory
exchange ratio (RER) of mutant mice was signiﬁcantly lower than
that of control mice, suggesting a preference of mutant mice to
metabolize fat as an energy source (Fig. 4B). This difference in RER
is unlikely to be a feedback response to variable fat composition as
there is no difference in body weight, or fat composition, at this
age. While the cause of reduction in RER in mutant mice is not
clear, this may be an alternate mechanism by which mutant mice
achieve reduced adiposity after 5 months. Oxygen consumption
(Fig. 4C), carbon dioxide production (Fig. 4D), total energy expen-
diture (Fig. 4E and F), and locomotor activity (Fig. 4G and H) were
all similar between control and mutant mice at age 3–4 months.
Rectal temperature was not statistically different between male
control and mutant mice, but was signiﬁcantly reduced in female
mutant mice (po0.01) (Fig. 4I). The cause of decreased body
temperature in mutant female mice is unclear.
Mutant mice had reduced hypothalamic cGMP concentration
As an important signaling molecule, NO mediates feeding;
furthermore, our previous data indicate that mutant mice had
Table 1
Blood parameters of control and mutant micea.
Measurement Age (m) Control Mutant p
Letpin (ng/ml) 3 2.670.5 (8) 4.071.0 (6) ns
16 20.473.0 (5) 10.771.2 (8) 0.03
Insulin (ng/ml) 3 0.3370.01 (11) 0.3370.02 (10) ns
16 1.1870.30 (18) 0.4470.04 (18) 0.028
FFA (μM) 3 514.1730.4 (10) 580.4738.8 (10) ns
16 1210780.7 (9) 1278794.6 (9) ns
Cholesterol (mg/dl) 16 219.3711.0 (10) 224.7710.3 (9) ns
Triglyceride (mg/dl) 12 124.279.6 (18) 53.378.5 (7) 0.0003
a Mean7SEM are present with number of female mice assayed in parentheses.
po0.05 by t-test was taken as signiﬁcant. ns, Not signiﬁcant.
Table 2
Food intake of control and mutant micea.
Mice Controls Mutants p
Female (2-3 m) Body weight (g) 23.371.1 (12) 23.470.8 (17) ns
Food/mouse/day (g) 4.270.14 (5) 3.070.08 (5) 0.00005
Daily food/bodyweight 0.17270.003 (5) 0.12370.007 (5) 0.0003
Male (13 m) Body weight (g) 44.271.6 (8) 3371.7 (8) 0.00036
Food/mouse/day (g) 4.370.20 (8) 4.070.10 (8) 0.17
a Mean7SEM for number of animals in parentheses are present. po0.05 considered signiﬁcant. ns, Not signiﬁcant.
C. Han et al. / Redox Biology 1 (2013) 498–507 501
Fig. 2. Reduced food intake in mutant mice. (A) Accumulative food intake during 24 h. (B) Comparing food intake in 4-h blocks. (C) Number of meals in 4-h blocks. (D) Time
spent on feeding in 4-h blocks. (E) Food intake of fasted mice during 9:0013:00. (F) Food intake of fasted mice during 16:0020:00. (G) Quantitative RT-PCR revealed
similar hypothalamic expression of genes involved in feeding control. 4-month-old female mice were assayed. Means7SEM for nZ5 animals per group are represented. *, **
and ***, po0.05, po0.01 and po0.0001, respectively, by Bonferroni post-tests following ANOVA.
C. Han et al. / Redox Biology 1 (2013) 498–507502
elevated mitochondrial superoxide generation, which caused
erectile dysfunction and defective oogenesis, which may result
from reduced NO bioavailability [35]. Therefore, our study focused
on the relationship between reduced food intake and NO bioavail-
ability in the hypothalamus. In the central nervous system, soluble
guanylate cyclase is the primary receptor for NO, which transforms
guanosine monophosphate (GMP) into cyclic GMP (cGMP). Due to
the difﬁculty in assaying NO, we measured the concentrations of
cGMP, the product of NO action, in the hypothalami of control and
mutant mice. Mutant mice, indeed, had signiﬁcantly reduced
hypothalamic cGMP concentration (po0.01, Fig. 5A), indicating
low NO in the hypothalamus of mutant mice. Expression of soluble
guanylate cyclase, the major receptor for NO, and nitric oxide
synthases, which are the genes that synthesize NO in vivo, was not
reduced in mutant hypothalami (Fig. 5B). On the contrary, mutant
mice had signiﬁcantly increased expression of nNOS and iNOS
(po0.05). The increased expression of nNOS and iNOS are con-
sistent with a feedback response to reduction in NO bioavailability
in the mutants.
NO has three principal reactions in vivo: (1) binding to
guanylate cyclase to stimulate cGMP production, (2) reacting with
oxyhemoglobin to form nitrate, and (3) reacting with superoxide
to form peroxynitrite. Modiﬁcation of macromolecules by perox-
ynitrite limits the availability of NO to form nitrate. Since mutant
mice generate higher levels of superoxide to react with NO, more
peroxynitrite is produced and less NO will be converted to free
nitrate. As expected, hypothalamic lysates from mutant mice had
signiﬁcantly reduced nitrate/nitrite content than those from con-
trol mice (po0.05) (Fig. 5C). These data support our hypothesis
that higher mitochondrial superoxide generation in the mutant
mice will react with NO to form peroxynitrite and less NO is
available for activating its receptor guanylate cyclase.
We examined the phosphorylation of AMPKα in the hypotha-
lamus of mutant mice and found that it was hyperphosphorylated
compared to the control mice (Fig. 5D and E). Thus, decreased food
intake observed in mutant mice is not related to insufﬁcient AMPK
phosphorylation, but may be related to downstream targets
of AMPK.
Immp2l mutation has little effects on the food intake or obesity
of ob/ob mice
Nitric oxide is produced and functions both pre- and post-
synaptically [44]. Recently, it has been shown that knockout of
leptin receptor in Nos1-positive neurons produces obesity similar
to ob/ob mice [45]. Therefore, we studied the effects of Immp2l
mutation on food intake of ob/ob mice to determine whether
Immp2l mutation could affect food intake through perturbation of
leptin signaling. We introduced the Immp2l mutation to ob/ob
mice, then we assessed at the age of 8 weeks that Immp2l /;
ob/ob mice had similar food intake compared to ob/ob mice
(8.270.28, N¼10 for ob/ob mice; 7.770.34, N¼4 for Immp2l /;
ob/ob mice, p¼0.35, data were from equal numbers of male and
female mice, which were not signiﬁcantly different). In addition,
obesity of Immp2l /ob/ob mice was comparable to obesity in
ob/ob mice (Fig. 6). Our data indicate that Immp2l mutation has
little effect on the food intake and obesity of ob/ob mice.
Discussion
In the present study, we report that Immp2l mutant mice have
reduced body weight and adiposity after the age of 5 months,
compared with control mice. Our data show that decreased body
weight and adiposity is the direct result of food intake reduction.
First, food intake is reduced by 30% in mutant mice; moreover, the
degree of reduction did not affect the development of mutant
mice, but it did reduce energy surplus as the mice reached
adulthood, and they did not gain weight. Second, feeding control
mice the equivalent amount of food consumed by mutant mice
Fig. 3. Pair-feeding equalized the body weight and fat composition of control and mutant mice. (A) Body weight and adiposity of mutant mice and normal mice fed the food
consumed by mutant mice. MRI was conducted on female mice at the age of 6 months (n¼5 for each group). (B) Fewer and smaller ADSC colonies were obtained from fat
tissue of mutant mice. (C) Fewer cells could be obtained from mutant ADSC after in vitro culture. For (B) and (C), normal mice were pair-fed. Data represented three pairs of
mice assayed at the age of 2225 months.
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Fig. 4. Normal energy expenditure of mutant mice. (A) Similar body weight of mice in metabolism analysis. (B) Mutant mice have reduced respiratory exchange ratio (RER).
(C) Proﬁle of oxygen consumption. (D) Proﬁle of carbon dioxide production. (E) Proﬁle of total energy expenditure. (F) Total energy expenditure during light and dark cycle.
(G) Proﬁle of ambulatory activity. (H) Total ambulatory activity during light and dark cycle. (I) Rectal temperature. Means7SEM for nZ5 animals per group are represented.
*, ** and ***, po0.05, po0.01 and po0.0001, respectively, by Bonferroni post-tests following ANOVA.
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equalized body weight and adiposity of the control mice. Third,
energy expenditure of mutant mice was not signiﬁcantly affected.
Mutant mice do exhibit higher RER than control mice, which
suggests a preference for lipids as the substrate. Thus, this may be
one of the mechanisms leading to reduced adiposity. Further
studies will be needed to conﬁrm the mechanism of RER change
in the mutant mice.
As previously reported by our group, mitochondria from
mutant mice generated increased levels of superoxide, which
reacts with NO and reduces the bioavailability of nitric oxide and
may explain the erectile dysfunction observed in mutant males
[35]. Nitric oxide has been shown to stimulate feeding in rodents
in multiple reports [6–13]. Reduced bioavailability of nitric oxide
in the brain of mutant mice may also be the mechanism for food
intake decrease. To support this view, we observed that hypotha-
lami of mutant mice have reduced levels of cGMP, the product of
nitric oxide signaling [44]. Although mutant mice had reduced
brain cGMP levels, expression of nitric oxide synthases, genes
encoding the enzymes that synthesize nitric oxide, was increased.
This is consistent with reduced nitric oxide bioavailability due to
excessive mitochondrial superoxide negation in the mutants. We
injected control and mutant mice with NO donor nitroprusside,
and found that food intakes in control and mutant mice were both
increased but showed no difference between genotypes (data not
shown). This suggests that the NO signaling machinery in mutant
mice is functional, and that the exogenous provided NO is able to
saturate the sCG for maximal NO signaling after reaction with
mitochondrial superoxide.
A direct comparison of NO concentrations between control and
mutant mice could strengthen our argument. However, measure-
ment of NO concentration in biological samples is a difﬁcult task.
Fluorescent probes usually lack the speciﬁcity, and electrochemical
sensors are in developing stages and not easily accessible. Restor-
ing food intake of mutant mice with antioxidants could be another
way to prove our hypothesis. These novel antioxidants must be
blood-brain barrier permeable, can either reduce mitochondrial
superoxide generation, or dismutate superoxide at a speed faster
than the reaction between superoxide and NO. To the best of our
knowledge, antioxidants meeting these criteria are unavailable
so far.
We observed that, AMPK, whose phosphorylation stimulates
NO production and food intake [27,28], is hyperphosphorylated in
mutant mice. This might be a feedback response to insufﬁcient NO
signaling. Peroxynitrite has been shown to activate AMPK [46];
and, hyperphosphorylaion of AMPK in the mutants may be the
result of increased production of peroxynitrite in the mutants.
Currently, the neural circuits affected in the mutants are
unclear. It has been shown recently that knockout of leptin
receptor in Nos1-positive neurons produces obesity similar to
ob/ob mice [45], which indicates that these neurons are the major
sites of leptin signaling. The role of NO in leptin signaling remains
unclear. We mutated Immp2l gene in ob/ob mice and found that it
had little effect on the food intake and obesity of ob/ob mice.
Among the possible explanations for our observations are (1)
Immp2l mutation has no effect on NO signaling, and Immp2l
mutation in ob/obmice would have little effect on leptin signaling;
and (2) Immp2lmutation will affect NO signaling, but NO signaling
does not play a critical role in leptin signaling. We do not believe
the ﬁrst explanation is a possibility since we observed erectile
Fig. 5. Analysis of NO signaling and AMPK phosphorylation. (A) Mutant mice have decreased hypothalamic cGMP concentration. (B) Quantitative RT-PCR analysis of
hypothalamic expression of genes encoding nitric oxide synthase (NOS) and soluble guanylate cyclase (sGC). (C) Mutant mice had decreased free hypothalamic nitrate and
nitrite content. Means7SEM for nZ5 animals per group are represented. (D) Western blotting analysis of AMPK phosphorylation. (E) Relative expression of phosphorylated
AMPK by integrated density of ImageJ software. For (A)(C) and (E), * and **, po0.05 and po0.01, respectively, by t-tests.
Fig. 6. Immp2l mutation in ob/ob mice did not signiﬁcantly affect their obesity.
Picture was taken on male mice at the age of 9 weeks.
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dysfunction and bladder dysfunction in mutants, which suggests
abnormal NO signaling [35,36]. The second explanation is more
likely, and would suggest that alternate pathways that regulating
feeding are affected in Immp2l mutant mice, and the effects of
these pathways are overridden in the absence of leptin. Support-
ing this view, Immp2l mutant mice ate as much as control mice
after fasting, and leptin level was decreased [47].
Adipose-derived stromal cells (ADSCs) isolated from older
mutant mice did not proliferate well [38]. Since ADSC frommutant
mice still showed impaired proliferation compared with those
from pair-fed control mice, the defects may not be secondary to
changes in adiposity. Furthermore, age-related defects such as
ataxia in Immp2l mutant mice may not be secondary to reduction
in food intake either. We observed that pair-fed control mice do
not exhibit ataxia at the age of 16 months as the ad libitum-
mutant mice do at the same age. A 30% diet restriction has been
shown to slow aging [48,49]. Despite the fact that Immp2l mutant
mice have reduced food intake, early onset of age-associated
defects has been observed [38], which highlights the important
role of ROS in aging.
In conclusion, Immp2l mutant mice have reduced body weight
and adiposity resulting from reduced food intake, which in turn,
could be linked to insufﬁcient NO signaling, due to negation of NO
by superoxide.
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